Literature DB >> 27072829

Resistant Hypertension and Chronic Kidney Disease: a Dangerous Liaison.

Martin J Wolley1,2, Michael Stowasser3.   

Abstract

Treatment-resistant hypertension is an increasingly recognised problem and is markedly over-represented in patients with chronic kidney disease (CKD). Recent evidence has clarified the heightened risk for both adverse renal and cardiovascular outcomes associated with resistant hypertension, even when blood pressure control is attained. The diagnosis of resistant hypertension in CKD is reliant on accurate blood pressure measurement, and out of office measurements are important due to the high prevalence of masked hypertension in these patients. Treatment strategies include careful dietary measures to restrict sodium intake, and a focus on improving adherence to antihypertensive medications. Medication choices should focus on a sensible foundation and then diuretic titration to combat the salt and volume retention inherent in CKD. In this review, we discuss the epidemiology, pathogenesis and consequences of resistant hypertension in CKD, and then review the optimal diagnostic and management strategies.

Entities:  

Keywords:  CKD; Chronic kidney disease; Resistant hypertension

Mesh:

Substances:

Year:  2016        PMID: 27072829     DOI: 10.1007/s11906-016-0641-x

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  94 in total

Review 1.  Loop diuretics: from the Na-K-2Cl transporter to clinical use.

Authors:  Sudha S Shankar; D Craig Brater
Journal:  Am J Physiol Renal Physiol       Date:  2003-01

2.  Hyperaldosteronism among black and white subjects with resistant hypertension.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Roopal B Thakkar; Paula Weissmann
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

3.  2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension.

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stephane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  Blood Press       Date:  2013-12-20       Impact factor: 2.835

4.  High prevalence of unrecognized sleep apnoea in drug-resistant hypertension.

Authors:  A G Logan; S M Perlikowski; A Mente; A Tisler; R Tkacova; M Niroumand; R S Leung; T D Bradley
Journal:  J Hypertens       Date:  2001-12       Impact factor: 4.844

Review 5.  Hypertension diagnosis and prognosis in chronic kidney disease with out-of-office blood pressure monitoring.

Authors:  Rajiv Agarwal
Journal:  Curr Opin Nephrol Hypertens       Date:  2006-05       Impact factor: 2.894

6.  Declining kidney function increases the prevalence of sleep apnea and nocturnal hypoxia.

Authors:  David D M Nicholl; Sofia B Ahmed; Andrea H S Loewen; Brenda R Hemmelgarn; Darlene Y Sola; Jaime M Beecroft; Tanvir C Turin; Patrick J Hanly
Journal:  Chest       Date:  2012-01-05       Impact factor: 9.410

7.  Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension.

Authors:  Monique N Pratt-Ubunama; Mari K Nishizaka; Robyn L Boedefeld; Stacey S Cofield; Susan M Harding; David A Calhoun
Journal:  Chest       Date:  2007-02       Impact factor: 9.410

8.  Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.

Authors:  G L Bakris; M R Weir; V DeQuattro; F G McMahon
Journal:  Kidney Int       Date:  1998-10       Impact factor: 10.612

9.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

10.  Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial.

Authors:  Liesbeth Bax; Arend-Jan J Woittiez; Hans J Kouwenberg; Willem P T M Mali; Erik Buskens; Frederik J A Beek; Branko Braam; Frans T M Huysmans; Leo J Schultze Kool; Matthieu J C M Rutten; Cornelius J Doorenbos; Johannes C N M Aarts; Ton J Rabelink; Pierre-François Plouin; Alain Raynaud; Gert A van Montfrans; Jim A Reekers; Anton H van den Meiracker; Peter M T Pattynama; Peter J G van de Ven; Dammis Vroegindeweij; Abraham A Kroon; Michiel W de Haan; Cornelis T Postma; Jaap J Beutler
Journal:  Ann Intern Med       Date:  2009-05-04       Impact factor: 25.391

View more
  7 in total

1.  Brazilian Position Statement on Resistant Hypertension - 2020.

Authors:  Juan Carlos Yugar-Toledo; Heitor Moreno Júnior; Miguel Gus; Guido Bernardo Aranha Rosito; Luiz César Nazário Scala; Elizabeth Silaid Muxfeldt; Alexandre Alessi; Andrea Araújo Brandão; Osni Moreira Filho; Audes Diógenes de Magalhães Feitosa; Oswaldo Passarelli Júnior; Dilma do Socorro Moraes de Souza; Celso Amodeo; Weimar Kunz Sebba Barroso; Marco Antônio Mota Gomes; Annelise Machado Gomes de Paiva; Eduardo Costa Duarte Barbosa; Roberto Dischinger Miranda; José Fernando Vilela-Martin; Wilson Nadruz Júnior; Cibele Isaac Saad Rodrigues; Luciano Ferreira Drager; Luiz Aparecido Bortolotto; Fernanda Marciano Consolim-Colombo; Márcio Gonçalves de Sousa; Flávio Antonio de Oliveira Borelli; Sérgio Emanuel Kaiser; Gil Fernando Salles; Maria de Fátima de Azevedo; Lucélia Batista Neves Cunha Magalhães; Rui Manoel Dos Santos Póvoa; Marcus Vinícius Bolívar Malachias; Armando da Rocha Nogueira; Paulo César Brandão Veiga Jardim; Thiago de Souza Veiga Jardim
Journal:  Arq Bras Cardiol       Date:  2020 May-Jun       Impact factor: 2.000

Review 2.  New Molecules for Treating Resistant Hypertension: a Clinical Perspective.

Authors:  Omar Azzam; Marcio G Kiuchi; Jan K Ho; Vance B Matthews; Leslie Marisol Lugo Gavidia; Janis M Nolde; Revathy Carnagarin; Markus P Schlaich
Journal:  Curr Hypertens Rep       Date:  2019-09-10       Impact factor: 5.369

3.  Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study.

Authors:  Rajiv Agarwal; Patrick Rossignol; Dahlia Garza; Martha R Mayo; Suzette Warren; Susan Arthur; Alain Romero; William B White; Bryan Williams
Journal:  Am J Nephrol       Date:  2018-09-03       Impact factor: 3.754

4.  A feared combination: Hypertension and chronic kidney disease.

Authors:  Paola Varleta; Rodrigo Tagle
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-11-14       Impact factor: 3.738

5.  Antihypertensive therapy prescribing patterns and correlates of blood pressure control among hypertensive patients with chronic kidney disease.

Authors:  Oyunbileg Magvanjav; Rhonda M Cooper-DeHoff; Caitrin W McDonough; Yan Gong; Mark S Segal; William R Hogan; Julie A Johnson
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-11-14       Impact factor: 3.738

6.  Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.

Authors:  Francesca Viazzi; Pamela Piscitelli; Antonio Ceriello; Paola Fioretto; Carlo Giorda; Pietro Guida; Giuseppina Russo; Salvatore De Cosmo; Roberto Pontremoli
Journal:  J Am Heart Assoc       Date:  2017-09-22       Impact factor: 5.501

7.  Reduced Renal Mass, Salt-Sensitive Hypertension Is Resistant to Renal Denervation.

Authors:  Ionut Tudorancea; Thomas E Lohmeier; Barbara T Alexander; Dragos Pieptu; Dragomir N Serban; Radu Iliescu
Journal:  Front Physiol       Date:  2018-04-30       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.